Product Information
AFREZZA ((REGULAR INSULIN) 8 UNIT CARTRIDGE is a brand product labeled by Mannkind Corporation, priced at $10.3476 per EA under NDC 47918087890. Its NADAC has been published 88 times since Oct 23, 2024.
Strength
8 [arb'U]/1
Manufacturer
Mannkind CorporationNDC
47918087890
Classification
Brand
Dosage Form
POWDER, METERED
Route
RESPIRATORY (INHALATION)
Last Updated
4/1/2026
Active Ingredients
INSULIN HUMANApproval Type
Biologic (BLA)
FDA Application
BLA022472On Market Since
7/1/2017
Pharmacological Classes
Price Statistics
The NADAC for AFREZZA ((REGULAR INSULIN) 8 UNIT CARTRIDGE has been published 88 times since Oct 23, 2024, and over the history we have for it it has risen 7.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.3476 per EA |
|---|---|
| All-time high | $10.3476 (Jun 24, 2026) |
| All-time low | $9.6209 (Oct 23, 2024) |
| 52-week high | $10.3476 |
| 52-week low | $10.0511 |
| Median price | $10.1057 |
| Average price | $10.0897 |
| Largest weekly change | +5.0% (Dec 18, 2024) |
| Weeks tracked | 88 |
| Tracking since | Oct 23, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the INSULIN HUMAN market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of AFREZZA ((REGULAR INSULIN) 8 UNIT CARTRIDGE?
The current National Average Drug Acquisition Cost (NADAC) for AFREZZA ((REGULAR INSULIN) 8 UNIT CARTRIDGE, manufactured by Mannkind Corporation, is $10.3476 per EA (NDC 47918087890), effective Jun 24, 2026.
How has the price of AFREZZA ((REGULAR INSULIN) 8 UNIT CARTRIDGE changed over time?
Over the history we have for it, the NADAC for AFREZZA ((REGULAR INSULIN) 8 UNIT CARTRIDGE has risen 7.6%. It has been tracked across 88 weekly CMS publications since Oct 23, 2024.
What are the highest and lowest recorded NADAC prices for AFREZZA ((REGULAR INSULIN) 8 UNIT CARTRIDGE?
Since Oct 23, 2024, the NADAC for AFREZZA ((REGULAR INSULIN) 8 UNIT CARTRIDGE has ranged from a low of $9.6209 (Oct 23, 2024) to a high of $10.3476 (Jun 24, 2026), with a median of $10.1057 per EA.
Are there cheaper alternatives to AFREZZA ((REGULAR INSULIN) 8 UNIT CARTRIDGE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AFREZZA ((REGULAR INSULIN) 8 UNIT CARTRIDGE, so no direct lower-cost alternative is listed.
Who manufactures AFREZZA ((REGULAR INSULIN) 8 UNIT CARTRIDGE?
AFREZZA ((REGULAR INSULIN) 8 UNIT CARTRIDGE (NDC 47918087890) is labeled by Mannkind Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification